Related Experiment Video

Updated: Jun 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Finding ALK-positive lung cancer: what are we really looking for?

D Ross Camidge, Fred R Hirsch, Marileila Varella-Garcia

    Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
    |February 15, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    Related Concept Videos

    lncRNA - Long Non-coding RNAs02:39

    lncRNA - Long Non-coding RNAs

    In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE).

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases.

    Cancer research communications·2026

    Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

    JTO clinical and research reports·2026

    First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

    The New England journal of medicine·2026

    High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.

    Clinical lung cancer·2026

    Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.

    Neuro-oncology·2026

    Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Lung Cancer Patient Advocacy Progress and New Challenges Since 2006.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

    Retina (Philadelphia, Pa.)·2026

    Preoperative Diagnosis of the Bile Duct Traumatic Neuroma by Endoscopic Ultrasound-guided Tissue Acquisition: A Case Report.

    DEN open·2026

    Severe hypercalcemia in a patient with end-stage liver disease.

    JCEM case reports·2026

    Endoscopic submucosal dissection for a giant circumferential early rectal cancer with massive schistosoma egg deposition: a case report.

    Frontiers in surgery·2026

    UNC93B1 drives IL-6/STAT3-dependent tumor-macrophage crosstalk and epithelial-mesenchymal transition in breast cancer.

    Frontiers in pharmacology·2026

    Early esophageal squamous neoplasia and the microbiome: evidence, mechanisms, and early-detection potential.

    Frontiers in microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us